BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21947243)

  • 1. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.
    Lin L; Zhong K; Sun Z; Wu G; Ding G
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):11-22. PubMed ID: 21947243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for advanced glycation end products is associated with autophagy in the clear cell renal cell carcinoma.
    Guo Y; Zhang HC; Xue S; Zheng JH
    J Cancer Res Ther; 2019; 15(2):317-323. PubMed ID: 30964104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
    Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.
    Riuzzi F; Sorci G; Donato R
    Am J Pathol; 2007 Sep; 171(3):947-61. PubMed ID: 17640970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines.
    Chen RC; Yi PP; Zhou RR; Xiao MF; Huang ZB; Tang DL; Huang Y; Fan XG
    Mol Cell Biochem; 2014 May; 390(1-2):271-80. PubMed ID: 24510323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells.
    Amornsupak K; Thongchot S; Thinyakul C; Box C; Hedayat S; Thuwajit P; Eccles SA; Thuwajit C
    BMC Cancer; 2022 May; 22(1):578. PubMed ID: 35610613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line.
    Choi J; Lee MK; Oh KH; Kim YS; Choi HY; Baek SK; Jung KY; Woo JS; Lee SH; Kwon SY
    Tumori; 2011; 97(2):196-202. PubMed ID: 21617715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance.
    Qie GQ; Wang CT; Chu YF; Wang R
    Int J Clin Exp Pathol; 2015; 8(6):6262-8. PubMed ID: 26261503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration.
    Bassi R; Giussani P; Anelli V; Colleoni T; Pedrazzi M; Patrone M; Viani P; Sparatore B; Melloni E; Riboni L
    J Neurooncol; 2008 Mar; 87(1):23-33. PubMed ID: 17975708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
    Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
    Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells.
    Gross C; Belville C; Lavergne M; Choltus H; Jabaudon M; Blondonnet R; Constantin JM; Chiambaretta F; Blanchon L; Sapin V
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):14. PubMed ID: 32176265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway.
    Kim SW; Lim CM; Kim JB; Shin JH; Lee S; Lee M; Lee JK
    Neurotox Res; 2011 Aug; 20(2):159-69. PubMed ID: 21116767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.
    Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S
    Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation.
    Tancharoen S; Tengrungsun T; Suddhasthira T; Kikuchi K; Vechvongvan N; Tokuda M; Maruyama I
    Mediators Inflamm; 2014; 2014():754069. PubMed ID: 25114379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.
    Takeuchi A; Yamamoto Y; Munesue S; Harashima A; Watanabe T; Yonekura H; Yamamoto H; Tsuchiya H
    Cancer Sci; 2013 Jun; 104(6):740-9. PubMed ID: 23421467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
    Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
    Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW
    Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein.
    Zhang T; Hu X; Cai Y; Yi B; Wen Z
    Mol Biol Rep; 2014 Mar; 41(3):1335-40. PubMed ID: 24420848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.